Exercise-induced ST-segment depression and systolic dysfunction in patients with nonobstructive hypertrophic cardiomyopathy

American Heart Journal

Volumn 140, Issue 1, 2000, Pages 52-60

  Shimizu, Masami ^a   Ino, Hidekazu ^a   Okeie, Kazuyasu ^a   Emoto, Yorito ^a   Yamaguchi, Masato ^a   Yasuda, Toshihiko ^a   Fujino, Noboru ^a   Fujii, Hiroyuki ^a   Fujita, Shinichiro ^a   Mabuchi, Tomohito ^a   Taki, Junichi ^a   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CORONARY ARTERY; CORONARY HEMODYNAMICS; EXERCISE; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART VENTRICLE VOLUME; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; SYSTOLE;

EID: 0033913838     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.106642     Document Type: Article

References (37)

1. Posma JL, van der Wall EE, Blanksma PK, et al. New diagnostic options in hypertrophic cardiomyopathy. Am Heart J 1996;132:1031-41.
2. Pitcher D, Wainwright R, Maisey M, et al. Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy. Br Heart J 1980;44:650-6.
3. O'Gara PT, Bonow RO, Maron BJ, et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201emission computed tomography. Circulation 1987;76:1214-23.
4. Dilsizian V, Bonow RO, Epstein SE, et al. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993;22:796-804.
5. Cannon RO III, Rosing DR, Maron BJ, etal. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985;71:234-43.
6. Cannon RO III, Schenke WH, Maron BJ, et al. Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 1987;10:53-62.
7. Pasternac A, Noble J, Streulens Y, et al. Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation 1982;65:778-89.
8. Maron BJ, Wolfson JK, Epstein SE, et al. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8:545-57.
9. Tanaka M, Fujiwara H, Onodera T, et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987;75:1130-9.
10. Krams R, Kofflard MJM, Duncker DJ, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation 1998;97:230-3.
11. Cannon RO III, Dilsizian V, O'Gara PT, et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991;83:1660-7.
12. Taki J, Yasuda T, Tamaki N, et al. Temporal relation between left ventricular dysfunction and chest pain in coronary artery disease during activities of daily living. Am J Cardiol 1990;66:1455-8.
13. Taki J, Muramori A, Nakajima K, et al. Application of a continuous ventricular function monitor with miniature cadmium telluride detector to patients with coronary artery bypass grafting. J Nucl Med 1992;33:441-7.
14. Taki J, Nakajima K, Shimizu M, et al. Left ventricular functional reserve in nonobstructive hypertrophic cardiomyopathy: evaluation by continuous left ventricular function monitoring. J Nucl Med 1994;35:1937-43.
15. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 1979;43:1242-4.
16. Brockenbrough EC, Braunwald E, Morrow AG. A hemodynamic technique for the detection of hypertrophic subaortic stenosis. Circulation 1961;23:189-94.
17. Yoshio H, Shimizu M, Kita Y, et al. Left ventricular functional reserve in patients with syndrome X: evaluation by continuous ventricular function monitoring. J Am Coll Cardiol 1993;22:1465-9.
18. Tanaka T, Friedman MJ, Okada RD, et al. Diagnostic value of exercise-induced S-T segment depression in patients with right bundle branch block. Am J Cardiol 1978;41:670-3.
19. Schwartzkopff B, Mundhenke M, Strauer BE. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: A possible cause for myocardial ischemia. J Am Coll Cardiol 1998;31:1089-96.
20. Crowley JJ, Dardas PS, Harcombe AA, et al. Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy. Heart 1997;77:558-63.
21. Pichard AD, Meller J, Teichholz LE, et al. Septal perforator compression (narrowing) in idiopathic hypertrophic cardiomyopathy. Am J Cardiol 1977;40:310-4.
22. Nienaber CA, Gambhir SS, Mody FV, et al. Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy. Circulation 1993;87:1580-90.
23. Elliott PM, Rosano GM, Gill JS, et al. Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy. Heart 1996;75:179-83.
24. Camici PG, Chiriatti G, Picano E, et al. Noninvasive identification of limited coronary flow reserve in hypertrophic cardiomyopathy. Coron Art Dis 1992;3:513-21.
25. Elliott PM, Kaski JC, Prasad K, et al. Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study. Eur Heart J 1996;17:1056-64.
26. Geisterfer-Lowrance AAT, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain gene missense mutation. Cell 1990;62:999-1006.
27. Schwartz K, Carrier L, Guicheney P, et al. Molecular basis of familial cardiomyopathies. Circulation 1995;91:532-40.
28. Thierfelder L, Watkins H, MacRae C, et al. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994;77:701-12.
29. Kimura A, Harada H, Park JE, et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997;16:379-82.
30. Carrier L, Bonne G, Bohrend E, et al. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res 1997;80:427-34.
31. 1. Chikamori T, Counihan PJ, Doi YL, et al. Mechanisms of exercise limitation in hypertrophic cardiomyopathy. J Am Coll Cardiol 1992;19:507-12.
32. Nihoyannopoulos P, Karatasakis G, Frenneaux M, et al. Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol 1992;19:536-40.
33. Lele SS, Thomson HL, Seo H, et al. Exercise capacity in hyper-trophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics. Circulation 1995;92:2886-94.
34. Maron BJ, Epstein SE, Roberts WC. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 1979;43:1086-102.
35. Lazzeroni E, Picano E, Morozzi L, et al. Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult patients with hypertrophic cardiomyopathy. Circulation 1997;96:4268-72.
36. Schwammenthal E, Schwarzkopff B, Block M, et al. Doppier echocardiographic assessment of the pressure gradient during bicycle ergometry in hypertrophic cardiomyopathy. Am J Cardiol 1992;69:1623-8.
37. Klues HG, Leuner C, Kuhn H. Left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: increase in gradient after exercise. J Am Coll Cardiol 1992;19:527-33.